Herein, we identified that SOCS2 could specifically expedite the ubiquitination degradation of SLC7A11 and thus contributed to ferroptosis and radiosensitization of HCC, indicating that targeting SOCS2 may represent a promising therapeutic strategy for HCC radiotherapy. This evidence concerns the gene SOCS2 and hepatocellular carcinoma.